22nd Century to Participate in the HC Wainwright Conference in New York City September 9, 2025
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference. The company's leadership, including CEO Larry Firestone and CFO Dan Otto, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel.
Interested investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations directly.
22nd Century Group (Nasdaq: XXII), azienda produttrice di prodotti del tabacco impegnata a ridurre i danni del fumo e la dipendenza da nicotina, parteciperà alla prossima conferenza HC Wainwright. La dirigenza, inclusi il CEO Larry Firestone e il CFO Dan Otto, terrà incontri con gli investitori il 9 settembre 2025 presso il Lotte New York Palace Hotel.
Gli investitori interessati possono fissare appuntamenti tramite il loro rappresentante HC Wainwright o contattando direttamente l'Investor Relations di 22nd Century.
22nd Century Group (Nasdaq: XXII), una compañía de productos de tabaco centrada en reducir los daños del tabaquismo y la adicción a la nicotina, ha anunciado su participación en la próxima conferencia HC Wainwright. La dirección de la empresa, incluidos el CEO Larry Firestone y el CFO Dan Otto, mantendrán reuniones con inversores el 9 de septiembre de 2025 en el Lotte New York Palace Hotel.
Los inversores interesados pueden programar reuniones a través de su representante de HC Wainwright o contactando directamente con Investor Relations de 22nd Century.
22nd Century Group (Nasdaq: XXII)는 흡연 피해와 니코틴 중독 감소에 주력하는 담배 제품 회사로, 곧 열리는 HC Wainwright 컨퍼런스에 참가한다고 발표했습니다. CEO Larry Firestone와 CFO Dan Otto를 포함한 경영진이 2025년 9월 9일 Lotte New York Palace Hotel에서 투자자 미팅을 진행할 예정입니다.
관심 있는 투자자는 HC Wainwright 담당자나 22nd Century의 투자자 관계팀에 직접 연락해 미팅을 예약할 수 있습니다.
22nd Century Group (Nasdaq: XXII), une entreprise de produits du tabac axée sur la réduction des méfaits du tabagisme et de la dépendance à la nicotine, a annoncé sa participation à la prochaine conférence HC Wainwright. La direction, y compris le CEO Larry Firestone et le CFO Dan Otto, tiendra des réunions avec des investisseurs le 9 septembre 2025 au Lotte New York Palace Hotel.
Les investisseurs intéressés peuvent planifier des rendez‑vous via leur représentant HC Wainwright ou en contactant directement les relations investisseurs de 22nd Century.
22nd Century Group (Nasdaq: XXII), ein Tabakproduktunternehmen, das sich auf die Verringerung der Schäden durch Rauchen und die Nikotinsucht konzentriert, hat seine Teilnahme an der bevorstehenden HC Wainwright-Konferenz angekündigt. Die Unternehmensführung, darunter CEO Larry Firestone und CFO Dan Otto, wird am 9. September 2025 im Lotte New York Palace Hotel Meetings mit Investoren abhalten.
Interessierte Investoren können Termine über ihren HC Wainwright-Vertreter oder direkt über die Investor-Relations-Abteilung von 22nd Century vereinbaren.
- None.
- None.
MOCKSVILLE, N.C., Sept. 05, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced that Larry Firestone, Chief Executive Officer, and Dan Otto, Chief Financial Officer, will host investor meetings on Tuesday, September 9, 2025 as part of the HC Wainwright Conference taking place at the Lotte New York Palace Hotel.
Investors can register and request meetings via their HC Wainwright representative or 22nd Century Investor Relations at mkreps@xxiicentury.com.
About 22nd Century Group, Inc.
22nd Century Group is pioneering the nicotine harm reduction movement in the tobacco industry enabling smokers to take control of their nicotine consumption.
We created our flagship product, the VLN® cigarette, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN® cigarettes have
Our proprietary non-GMO reduced nicotine tobacco blends are made possible by comprehensive and patented technologies and tobacco plants that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with
VLN® is a registered trademark of 22nd Century Limited LLC.
Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.
Learn more about VLN® at tryvln.com.
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200
